NCT00319761
- Conditions
- Autoimmune Diseases, Chronic Disease, Disease Attributes, +19 more
- Locations
-
- Department of Medicine & Therapeutics, Prince of Wales Hospital Hong Kong
Clinical trial condition
Glomerulonephritis, IGA
Explore clinical trials studying Glomerulonephritis, IGA. Study availability and eligibility vary by location and protocol.
190 public trials
56 recruiting studies
Glomerulonephritis, IGA trial results
NCT00755859
- Conditions
- Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +14 more
- Locations
-
- Hospital "Bolognini" Seriate, BG, Italy
- Hospital "Spedali Civili" Brescia, Italy
- Hospital of Montichiari Montichiari, Brescia, Italy
- "G. Brotzu" Hospital Cagliari, Italy
NCT00367562
- Conditions
- Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +14 more
- Locations
-
- Hospital Britanico de Buenos Aires Buenos Aires, Argentina
NCT00006137
- Conditions
- Autoimmune Diseases, Disease Attributes, Female Urogenital Diseases, +13 more
- Locations
-
Not specified
Completed
Study of Genetic Anomalies of Complement Related Proteins in Patients With IgA Glomerulonephritis
NCT00004305
- Conditions
- Autoimmune Diseases, Disease Attributes, Female Urogenital Diseases, +13 more
- Locations
-
- Ohio State University Columbus, Ohio, United States
Active, Not Recruiting
A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy
NCT04557462
- Conditions
- Autoimmune Diseases, Chronic Disease, Disease Attributes, +15 more
- Locations
-
- AZ Kidney Dise and Hypertension Ctr Glendale, Arizona, United States
- Kaiser Permanente San Diego, California, United States
- North America Research Institute San Dimas, California, United States
- University of Colorado Anschutz Aurora, Colorado, United States
Active, Not Recruiting
Trial of Sibeprenlimab in the Treatment of A Nephropathy (IgAN)
NCT05248646
- Conditions
- Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
- Locations
-
- University of Alabama at Birmingham - Site #336 Birmingham, Alabama, United States
- Mayo Clinic Arizona - Site #363 Phoenix, Arizona, United States
- University of Arkansas for Medical Sciences - Site #353 Little Rock, Arkansas, United States
- Amicis Research Center - Site #341 Granada Hills, California, United States
Active, Not Recruiting
Study of Ravulizumab in Immunoglobulin A Nephropathy (IgAN)
NCT06291376
- Conditions
- Autoimmune Diseases, Chronic Disease, Disease Attributes, +20 more
- Locations
-
- Research Site Alabaster, Alabama, United States
- Research Site Phoenix, Arizona, United States
- Research Site Los Angeles, California, United States
- Research Site Los Angeles, California, United States
Active, Not Recruiting
Atrasentan in Patients With IgA Nephropathy
NCT04573478
- Conditions
- Autoimmune Diseases, Chronic Disease, Disease Attributes, +16 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- Comprehensive Research Institute Alhambra, California, United States
- Kidney Disease Medical Group Glendale, California, United States
- Stanford University Stanford, California, United States
Active, Not Recruiting
Atrasentan in Patients With Proteinuric Glomerular Diseases
NCT04573920
- Conditions
- Alport Syndrome, Autoimmune Diseases, Collagen Diseases, +26 more
- Locations
-
- Kidney Disease Medical Group Glendale, California, United States
- Academic Medical Research Institute Los Angeles, California, United States
- North America Research Institute San Dimas, California, United States
- Stanford U School Of Medicine Stanford, California, United States